Shopping Cart 0
Cart Subtotal
USD 0

Takara Bio USA Inc-Pharmaceuticals & Healthcare-Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 750

Details

Summary

Takara Bio USA Inc (Takara Bio USA), formerly Clontech Laboratories, Inc. is a subsidiary of Takara Bio Inc is a healthcare company that provides kits, reagents, and services to researchers. The company's products include adenoviral transduction tools, adenoviral vector systems, apoptosis kits, cdna synthesis kits, cell biology kits, cloning enhancer, cloning kits, cloning vectors, competent cells and detection of tagged proteins. It offers epigenetics kits, fluorescent protein antibodies, fluorescent proteins, gene expression profiling, lentiviral transduction tools, lentiviral vector systems, microrna transfection, mrna amplification and mutagenesis reagents, among others. Takara Bio USA products find applications in cell biology, cell culture, epigenetics, inducible systems, nucleic acid purification, protein interactions and viral transduction. The company also provides contract research services. It offers products in different parts of the US. Takara Bio USA is headquartered in Mountain View, California, the US.

Takara Bio USA Inc-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Takara Bio USA Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Takara Bio USA Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

Takara Bio USA Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Takara Bio USA Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

Takara Bio USA Inc, Medical Devices Deals, 2011 to YTD 2017 9

Takara Bio USA Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10

Takara Bio USA Inc, Pharmaceuticals & Healthcare, Deal Details 11

Partnerships 11

Clontech Labs Enters Into Technology Integration Agreement With Rubicon Genomics 11

Licensing Agreements 12

Clontech Lab Enters into Licensing Agreement with Broad Institute for Crispr Gene Editing System 12

ARIAD Pharma Enters Into Licensing Agreement With Clontech Labs 13

Takara Bio USA Inc-Key Competitors 15

Key Employees 16

Locations And Subsidiaries 17

Head Office 17

Recent Developments 18

Product News 18

Feb 29, 2016: Clontech Laboratories Releases TaKaRa Taq Hot Start Version GMP Grade 18

Jan 20, 2016: Clontech Laboratories to Release a Highly Sensitive Kit for Human T-Cell Receptor Repertoire Analysis 19

Jan 11, 2016: Clontech Laboratories Releases a New Powerful Delivery Technology for CRISPR/Cas9-Mediated Gene Editing 20

Appendix 21

Methodology 21

About GlobalData 21

Contact Us 21

Disclaimer 21


List Of Figure

List of Figures

Takara Bio USA Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1

Takara Bio USA Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1

Takara Bio USA Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1

Takara Bio USA Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Takara Bio USA Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6

Takara Bio USA Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Takara Bio USA Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

Takara Bio USA Inc, Medical Devices Deals, 2011 to YTD 2017 9


List Of Table

List of Tables

Takara Bio USA Inc, Pharmaceuticals & Healthcare, Key Facts 1

Takara Bio USA Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Takara Bio USA Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

Takara Bio USA Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Takara Bio USA Inc, Deals By Therapy Area, 2011 to YTD 2017 8

Takara Bio USA Inc, Medical Devices Deals, 2011 to YTD 2017 9

Takara Bio USA Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10

Clontech Labs Enters Into Technology Integration Agreement With Rubicon Genomics 11

Clontech Lab Enters into Licensing Agreement with Broad Institute for Crispr Gene Editing System 12

ARIAD Pharma Enters Into Licensing Agreement With Clontech Labs 13

Takara Bio USA Inc, Key Competitors 15

Takara Bio USA Inc, Key Employees 16

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Takara Bio USA Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

Takara Bio USA Inc (Takara Bio USA), formerly Clontech Laboratories, Inc. is a subsidiary of Takara Bio Inc is a healthcare company that provides kits, reagents, and services to researchers. The company's products include adenoviral transduction tools, adenoviral vector systems, apoptosis kits, cdna synthesis kits, cell biology kits, cloning enhancer, cloning kits, cloning vectors, competent cells and detection of tagged proteins. It offers epigenetics kits, fluorescent protein antibodies, fluorescent proteins, gene expression profiling, lentiviral transduction tools, lentiviral vector systems, microrna transfection, mrna amplification and mutagenesis reagents, among others. Takara Bio USA products find applications in cell biology, cell culture, epigenetics, inducible systems, nucleic acid purification, protein interactions and viral transduction. The company also provides contract research services. It offers products in different parts of the US. Takara Bio USA is headquartered in Mountain View, California, the US.

Takara Bio USA Inc-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Takara Bio USA Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Takara Bio USA Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

Takara Bio USA Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Takara Bio USA Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

Takara Bio USA Inc, Medical Devices Deals, 2011 to YTD 2017 9

Takara Bio USA Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10

Takara Bio USA Inc, Pharmaceuticals & Healthcare, Deal Details 11

Partnerships 11

Clontech Labs Enters Into Technology Integration Agreement With Rubicon Genomics 11

Licensing Agreements 12

Clontech Lab Enters into Licensing Agreement with Broad Institute for Crispr Gene Editing System 12

ARIAD Pharma Enters Into Licensing Agreement With Clontech Labs 13

Takara Bio USA Inc-Key Competitors 15

Key Employees 16

Locations And Subsidiaries 17

Head Office 17

Recent Developments 18

Product News 18

Feb 29, 2016: Clontech Laboratories Releases TaKaRa Taq Hot Start Version GMP Grade 18

Jan 20, 2016: Clontech Laboratories to Release a Highly Sensitive Kit for Human T-Cell Receptor Repertoire Analysis 19

Jan 11, 2016: Clontech Laboratories Releases a New Powerful Delivery Technology for CRISPR/Cas9-Mediated Gene Editing 20

Appendix 21

Methodology 21

About GlobalData 21

Contact Us 21

Disclaimer 21


List Of Figure

List of Figures

Takara Bio USA Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1

Takara Bio USA Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1

Takara Bio USA Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1

Takara Bio USA Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Takara Bio USA Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6

Takara Bio USA Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Takara Bio USA Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

Takara Bio USA Inc, Medical Devices Deals, 2011 to YTD 2017 9


List Of Table

List of Tables

Takara Bio USA Inc, Pharmaceuticals & Healthcare, Key Facts 1

Takara Bio USA Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Takara Bio USA Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

Takara Bio USA Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Takara Bio USA Inc, Deals By Therapy Area, 2011 to YTD 2017 8

Takara Bio USA Inc, Medical Devices Deals, 2011 to YTD 2017 9

Takara Bio USA Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10

Clontech Labs Enters Into Technology Integration Agreement With Rubicon Genomics 11

Clontech Lab Enters into Licensing Agreement with Broad Institute for Crispr Gene Editing System 12

ARIAD Pharma Enters Into Licensing Agreement With Clontech Labs 13

Takara Bio USA Inc, Key Competitors 15

Takara Bio USA Inc, Key Employees 16

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Takara Bio USA Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.